Amicus Therapeutics has entered into a strategic gene therapy development and manufacturing collaboration with Brammer Bio, which is a part of Thermo Fisher Scientific. / read more /
New figures published by the ABPI have revealed the continuation of significant investment by the pharmaceutical industry into R&D in the United Kingdom. / read more /
advertisement
Subscribe
Subscribers can enjoy each full issue of Pharm Tech Europe in print, or via Pharm Tech Europe apps.
CHMP of the European Medicines Agency has recommended a change to the European marketing authorization for AstraZeneca's Forxiga (dapagliflozin) in patients with Type-2 diabetes. / read more /
FDA proposes rule to help ensure availability of hormones and enzymes formerly classified as drugs, and to stimulate biosimilars competition. / read more /
Quality and compliance depend on the right approaches to training, standard operating procedures, and validation. More tools are available to help ensure success. / read more /
Proactive approaches that consider long-term supply chain security compliance are recommended to ensure companies stay on the right track. / read more /
LCMS-9030 Q-TOF: Effortless performance
The LCMS-9030 of Shimadzu is a research grade mass spectrometer designed to deliver high-resolution, accurate mass detection with incredibly fast data acquisition rates, allowing scientists to identify and quantify more compounds with greater confidence. / Read more/
The editors explore novel technologies for the formulation, manufacture,
purification, and delivery of sterile small- and large-molecule drugs including single-use systems, facilities and equipment, contamination issues, and process analytics.
